
Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) showed a loss in earnings since Q3, totaling $75.96 million. Sales, on the other hand, increased by 1.84% to $1.37 billion during Q4. In Q3, Syneos Health earned $78.24 million and total sales reached $1.35 billion.